is bpc 157 on fda 503a bulks list BPC-157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this a positive vote. It does not immediately make… The Future of Peptide Compounding

The Future of Peptide Compounding Is on the Agenda Next Week FDA's July 2026 Peptide Compounding Meeting: What PCAC Could Change for BPC 157, TB 500, Semax, and More PeptideKnow I just testified at an FDA meeting on whether seven popular peptides should be allowed in compounding. Just last month, FDA medical officers determined that none of the peptides met the agency's BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Big week for peptides. On July 2324, the FDA's Pharmacy Compounding Advisory Committee will review seven peptide related groups for potential inclusion on the 503A Bulks List. The committee will hear evidence, discuss

SKU: 46838730749 · From southroadsurgery.com.au